New York, January 27, 2023. Allegations, gain of function and directed evolution research,
Friday, January 27, 2023 – 08:00pm
https://www.pfizer.com/news/announcements/pfizer-responds-research-claims#.Y9WTkZsflV4.mailto
the company would like to set the record straight.
Seek medical attention right away if you have any of the following symptoms:
Difficulty breathing, swelling of the face and throat, a fast heartbeat, a bad rash all over the body, dizziness, and weakness
Myocarditis (inflammation of the heart muscle)
Pericarditis (inflammation of the lining outside the heart),
have occurred in some people who have received COMIRNATY® (COVID-19 vaccine, mRNA) or Pfizer-BioNTech COVID-19 Vaccine.
The observed risk
Higher among adolescent males and adult males under 40 years of age
(compared to females and older males)
Risk is highest in males 12 through 17 years of age.
In most of these people
Symptoms began within a few days following receipt of the second dose of vaccine.
Magnitude of risk not specified in press release
From the recent ‘Vaccine’ paper
https://pubmed.ncbi.nlm.nih.gov/36055877/
Pfizer mRNA COVID-19 vaccines, associated with an excess risk of serious adverse events of special interest of 10.1 per 10,000 vaccinated
Moderna mRNA COVID-19 vaccines, associated with an excess risk of serious adverse events of special interest of 15.1 per 10,000 vaccinated
Combined, 1 in 800
Latest risk figures from UK Health Security Agency (UKHSA) presentation to the Joint Committee on Vaccination and Immunisation (JCVI)
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1131409/appendix-1-of-jcvi-statement-on-2023-covid-19-vaccination-programme-8-november-2022.pdf
Table 3: NNV for prevention of hospitalisation(and severe hospitalisation)for different programmes
16 – 19 Years, Autumn booster
73,500 (185,100)
20 – 29 Years, Autumn booster
No risk group, 169,200 (706,500)
In a risk group, 7,500 (59,500)
Side effects that have been reported with these vaccines include (direct from Pfizer)
Severe allergic reactions
Non-severe allergic reactions such as rash, itching, hives, or swelling of the face
Myocarditis
Pericarditis
Injection site pain
Tiredness
Headache
Muscle pain
Chills
Joint pain
Fever
Injection site swelling
Injection site redness
Nausea
Feeling unwell
Swollen lymph nodes (lymphadenopathy)
Decreased appetite
Diarrhea
Vomiting
Arm pain
Fainting in association with injection of the vaccine
Unusual and persistent irritability
Unusual and persistent poor feeding
Unusual and persistent fatigue or lack of energy
Unusual and persistent cool, pale skin
Dizziness
These may not be all the possible side effects of these vaccines.
Call the vaccination provider or healthcare provider about bothersome side effects or side effects that do not go away.
Individuals should always ask their healthcare providers for medical advice about adverse events.
Report vaccine side effects using Vaccine Adverse Event Reporting System (VAERS).
The VAERS toll-free number is 1‐800‐822‐7967 or report online to www.vaers.hhs.gov/reportevent.html.
In addition, individuals can report side effects to Pfizer Inc. at www.pfizersafetyreporting.com or by calling 1-800-438-1985
Tell your vaccination provider about all of your medical conditions, including if you:
have any allergies
have had myocarditis or pericarditis
have a fever
have a bleeding disorder or are on a blood thinner
are immunocompromised or are on a medicine that affects the immune system
are pregnant, plan to become pregnant, or are breastfeeding
have received another COVID-19 vaccine
have ever fainted in association with an injection
The vaccine may not protect everyone
Fact-based information rooted in sound science is vitally important to overcoming the COVID-19 pandemic,
and Pfizer remains committed to transparency and helping alleviate the devastating burden of this disease.
source
